Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-26T08:24:22.424Z Has data issue: false hasContentIssue false
  • English
  • Français

Peptide YY, appetite and food intake

Published online by Cambridge University Press:  07 March 2007

C. W. le Roux  and
S. R. Bloom
C. W. le Roux
Affiliation:
Department of Metabolic Medicine, Imperial College London, W12 0NN, UK
S. R. Bloom*
Affiliation:
Department of Metabolic Medicine, Imperial College London, W12 0NN, UK
*
*Corresponding author: Professor S. R. Bloom, fax +44 208 3838320, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Obesity is taking on pandemic proportions. The laws of thermodynamics, however, remain unchanged, as energy will be stored if less energy is expended than consumed; the storage is usually in the form of adipose tissue. Several neural, humeral and psychological factors control the complex process known as appetite. Recently, a close evolutionary relationship between the gut and brain has become apparent. The gut hormones regulate important gastrointestinal functions such as motility, secretion, absorption, provide feedback to the central nervous system on availability of nutrients and may play a part in regulating food intake. Peptide YY (PYY) is a thirty-six amino acid peptide related to neuropeptide Y (NPY) and is co-secreted with glucagon-like peptide 1. Produced by the intestinal L-cells, the highest tissue concentrations of PYY are found in distal segments of the gastrointestinal tract, although it is present throughout the gut. Following food intake PYY is released into the circulation. PYY concentrations are proportional to meal energy content and peak plasma levels appear postprandially after 1 h. PYY3-36 is a major form of PYY in both the gut mucosal endocrine cells and the circulation. Peripheral administration of PYY3-36 inhibits food intake for several hours in both rodents and man. The binding of PYY3-36 to the Y2 receptor leads to an inhibition of the NPY neurones and a possible reciprocal stimulation of the pro-opiomelanocortin neurones. Thus, PYY3-36 appears to control food intake by providing a powerful feedback on the hypothalamic circuits. The effect on food intake has been demonstrated at physiological concentrations and, therefore, PYY3-36 may be important in the everyday regulation of food intake.

Keywords

Peptide YYObesityAppetite regulationFood intake
Type
Postgraduate Symposium
Information
Proceedings of the Nutrition Society , Volume 64 , Issue 2 , May 2005 , pp. 213 - 216
Copyright
Copyright © The Nutrition Society 2005

References

Adrian, TE, Ballantyne, GH, Longo, WE, Bilchik, AJ, Graham, S, Basson, MD, Tierney, RP & Modlin, IM (1993) Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut 34, 1219–1224.CrossRefGoogle ScholarPubMed
Adrian, TE, Ferri, GL, Bacarese-Hamilton, AJ, Fuessl, HS, Polak, JM & Bloom, SR (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89, 1070–1077.CrossRefGoogle ScholarPubMed
Adrian, TE, Savage, AP, Bacarese-Hamilton, AJ, Wolfe, K, Besterman, HS & Bloom, SR (1986) Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 90, 379–384.CrossRefGoogle ScholarPubMed
Adrian, TE, Savage, AP, Fuessl, HS, Wolfe, K, Besterman, HS & Bloom, SR (1987) Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. Surgery 101, 715–719.Google ScholarPubMed
Adrian, TE, Savage, AP, Sagor, GR, Allen, JM, Bacarese-Hamilton, AJ, Tatemoto, K, Polak, JM & Bloom, SR (1985) Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89, 494–499.CrossRefGoogle ScholarPubMed
Anini, Y, Fu-Cheng, X, Cuber, JC, Kervran, A, Chariot, J & Roz, C (1999) Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflugers Archiv 438, 299–306.CrossRefGoogle ScholarPubMed
Batterham, RL, Cohen, MA, Ellis, SM, Le Roux, CW, Withers, DJ, Frost, GS, Ghatei, MA & Bloom, SR (2003) Inhibition of food intake in obese subjects by peptide YY3–36. New England Journal of Medicine 349, 941–948.CrossRefGoogle ScholarPubMed
Batterham, RL, Cowley, MA, Small, CJ, Herzog, H, Cohen, MA & Dakin, CL et al. . (2002) Gut hormone PYY (3–36) physiologically inhibits food intake. Nature 418, 650–654.CrossRefGoogle ScholarPubMed
Bonaz, B, Taylor, I & Tache, Y (1993) Peripheral peptide YY induces c-fos-like immunoreactivity in the rat brain. Neuroscience Letters 163, 77–80.CrossRefGoogle ScholarPubMed
Buchan, AMJ (1999) Nutrient tasting and signaling mechanisms in the gut. III Endocrine cell recognition of luminal nutrients. American Journal of Physiology 277, G1103–G1107.Google ScholarPubMed
Cannon, WB & Washburn, AL (1912) An explanation of hunger. American Journal of Physiology 29, 441–454.CrossRefGoogle Scholar
Challis, BG, Coll, AP, Yeo, GS, Pinnock, SB, Dickson, SL & Thresher, RR et al. . (2004) Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY3–36. Proceedings of the National Academy of Sciences USA 101, 4695–4700.CrossRefGoogle Scholar
Challis, BG, Pinnock, SB, Coll, AP, Carter, RN, Dickson, SL, O'Rahilly, S (2003) Acute effects of PYY3–36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochemical and Biophysical Research Communications 311, 915–919.CrossRefGoogle ScholarPubMed
Cowley, MA, Smart, JL, Rubinstein, M, Cerdan, MG, Diano, S, Horvath, TL, Cone, RD & Low, MJ (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480–484.CrossRefGoogle ScholarPubMed
Cowley, MA, Smith, RG, Diano, S, Tschop, M, Pronchuk, N & Grove, KL et al. . (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649–661.CrossRefGoogle ScholarPubMed
Cox, JE & Randich, A (2004) Enhancement of feeding suppression by PYY(3–36) in rats with area postrema ablations. Peptides 25, 985–989.CrossRefGoogle ScholarPubMed
Delgado-Aros, S, Cremonini, F, Castillo, JE, Chial, HJ, Burton, DD, Ferber, I & Camilleri, M (2004) Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology 126, 432–440.CrossRefGoogle ScholarPubMed
Deng, X, Guarita, DR, Pedroso, MR, Wood, PG, Kreiss, C, Sved, AF & Whitcomb, DC (2001) Area postrema lesion alters the effects of peptide YY on 2-DG-stimulated pancreatic exocrine secretion. Digestive Diseases and Sciences 46, 2460–2469.CrossRefGoogle ScholarPubMed
Dumont, Y, Fournier, A, St-Pierre, S & Quirion, R (1996) Autoradiographic distribution of [125I]Leu31, Pro34]PYY and [125I]PYY3–36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse 22, 139–158.3.0.CO;2-E>CrossRefGoogle ScholarPubMed
Eberlein, GA, Eysselein, VE, Schaeffer, M, Layer, P, Grandt, D, Goebell, H, Niebel, W, Davis, M, Lee, TD & Shively, JE (1989) A new molecular form of PYY: structural characterization of human PYY(3–36) and PYY(1–36). Peptides 10, 797–803.CrossRefGoogle ScholarPubMed
Finer, N (2003) Obesity. Clinical Medicine 3, 23–27.CrossRefGoogle ScholarPubMed
Flegal, KM, Carroll, MD, Ogden, CL & Johnson, CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. Journal of the American Medical Association 288, 1723–1727.CrossRefGoogle ScholarPubMed
Geiselman, PJ (1996) Control of food intake. A physiologically complex, motivated behavioral system. Endocrinology and Metabolism Clinics of North America 25, 815–829.CrossRefGoogle ScholarPubMed
Gibbs, J, Young, RC & Smith, GP (1973) Cholecystokinin decreases food intake in rats. Journal of Comparative Physiology and Psychology 84, 488–495.CrossRefGoogle ScholarPubMed
Grandt, D, Schimiczek, M, Beglinger, C, Layer, P, Goebell, H, Eysselein, VE, Reeve, JR Jr (1994) Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1–36 and PYY 3–36. Regulatory Peptides 51, 151–159.CrossRefGoogle ScholarPubMed
Hagan, MM (2002) Peptide YY: a key mediator of orexigenic behavior. Peptides 23, 377–382.CrossRefGoogle ScholarPubMed
Halatchev, IG, Ellacott, KL, Fan, W & Cone, RD (2004) Peptide YY3–36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 145, 2585–2590.CrossRefGoogle ScholarPubMed
Hill, JO, Wyatt, HR, Reed, GW & Peters, JC (2003) Obesity and the environment: where do we go from here. Science 299, 853–855.CrossRefGoogle Scholar
Imamura, M (2002) Effects of surgical manipulation of the intestine on peptide YY and its physiology. Peptides 23, 403–407.CrossRefGoogle ScholarPubMed
Jin, SL, Han, VK, Simmons, JG, Towle, AC, Lauder, JM & Lund, PK (1988) Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. Journal of Comparative Neurology 271, 529–532.Google Scholar
Kervran, A, Blache, P & Bataille, D (1987) Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat. Endocrinology 121, 704–713.CrossRefGoogle ScholarPubMed
Kirchgessner, AL & Liu, M (1999) Orexin synthesis and response in the gut. Neuron 24, 941–951.CrossRefGoogle ScholarPubMed
Leslie, RA, McDonald, TJ & Robertson, HA (1988) Autoradiographic localization of peptide YY and neuropeptide Y binding sites in the medulla oblongata. Peptides 9, 1071–1076.CrossRefGoogle ScholarPubMed
Lin, HC & Chey, WY (2003) Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs. Regulatory Peptides 114, 131–135.CrossRefGoogle ScholarPubMed
Lin, HC, Chey, WY & Zhao, X (2000) Release of distal gut peptide YY (PYY) by fat in proximal gut depends on CCK. Peptides 21, 1561–1563.CrossRefGoogle ScholarPubMed
Merchenthaler, I (1991) Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with fluoro-gold. Neuroscience 44, 655–662.CrossRefGoogle Scholar
Nicolaidis, S & Even, P (1985) Physiological determinant of hunger, satiation, and satiety. American Journal of Clinical Nutrition 42, 1083–1092.CrossRefGoogle Scholar
Nonaka, N, Shioda, S, Niehoff, ML & Banks, WA (2003) Characterization of blood-brain barrier permeability to PYY3–36 in the mouse. Journal of Pharmacology and Experimental Therapuetics 306, 948–953.CrossRefGoogle ScholarPubMed
Pedersen-Bjergaard, U, Host, U, Kelbaek, H, Schifter, S, Rehfeld, JF, Faber, J & Christensen, NJ (1996) Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scandinavian Journal of Clinical and Laboratory Investigation 56, 497–503.CrossRefGoogle ScholarPubMed
Pedersen-Bjergaard, U, Host, U, Kelbaek, H, Schifter, S, Rehfeld, JF, Faber, J & Christensen, NJ (1996) Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man. Scandinavian Journal of Clinical and Laboratory Investigation 56, 497–503.CrossRefGoogle ScholarPubMed
Pittner, RA, Moore, CX, Bhavsar, SP, Gedulin, BR, Smith, PA, Jodka, CM, Parkes, DG, Paterniti, JR, Srivastava, VP & Young, AA (2004) Effects of PYY[3–36] in rodent models of diabetes and obesity. International Journal of Obesity and Related Metabolic Disorders 28, 963–971.CrossRefGoogle ScholarPubMed
Potter, EK, Barden, JA, McCloskey, MJ, Selbie, LA, Tseng, A, Herzog, H & Shine, J (1994) A novel neuropeptide Y analog, N-acetyl [Leu28, Leu31]neuropeptide Y-(24–36), with functional specificity for the presynaptic (Y2) receptor. European Journal of Pharmacology 267, 253–262.CrossRefGoogle ScholarPubMed
Riediger, T, Bothe, C, Becskei, C & Lutz, TA (2004) Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-fos expression. Neuroendocrinology 79, 317–326.CrossRefGoogle ScholarPubMed
Rosenbaum, M, Leibel, RL & Hirsch, J (1997) Obesity. New England Journal of Medicine 337, 396–407.CrossRefGoogle ScholarPubMed
Schwartz, MW, Woods, SC, Porte, D Jr, Seeley, RJ, Baskin, DG (2000) Central nervous system control of food intake. Nature 404, 661–671.CrossRefGoogle ScholarPubMed
Tang-Christensen, M, Larsen, PJ, Thulesen, J, Romer, J & Vrang, N (2000) The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nature Medicine 6, 802–807.CrossRefGoogle ScholarPubMed
Tschop, M, Castaneda, TR, Joost, HG, Thone-Reineke, C, Ortmann, S & Klaus, S et al. . (2004) Physiology: does gut hormone PYY3–36 decrease food intake in rodents. Nature 430, 165–167.CrossRefGoogle ScholarPubMed
Ugolev, AM (1975) Non-digestive functions of the intestinal hormones (enterines). New data and hypotheses based on experimental duodenectomy. Acta Hepatogastroenterologica 22, 320–326.Google ScholarPubMed
Wren, AM, Small, CJ, Abbott, CR, Dhillo, WS, Seal, LJ, Cohen, MA, Batterham, RL, Taheri, S, Stanley, SA, Ghatei, MA & Bloom, SR (2001) Ghrelin causes hyperphagia and obesity in rats. Diabetes 50, 2540–2547.CrossRefGoogle ScholarPubMed